Infectious Diseases

Global Infectious Disease Testing/Microbiology Market Surveys of 92 Countries, Supplier Shares, Strategies, Segment Forecasts for 100 Lab/POC Tests, Analyzers and Consumables, Competitive Analyses, Technologies, Instrumentation Reviews, Opportunities

Wed, 06 Nov 2019 14:52:50 +0000

The following are the latest Infectanalyses not available from any other source, and include:

- Supplier shares by product and country - Volume and sales segment forecasts for over 100 virology, bacteriology, parasitology, and mycology tests; centralized and POC market segments; and nearly 100 countries. - Competitor strategies and SWOT analyses.

- World Virology, Bacteriology, Parasitology and Mycology Markets: A 92-Country Assessment $18,500 Content, Tables, S...

$0.00

2024-2029 Global Enteric Diseases Diagnostic Market for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia Tests: US, Europe, Japan—2024 Supplier Shares, Volume and Sales Segment Forecasts

Thu, 12 Dec 2024 16:46:19 +0000

This new report LeadingMarketResearch.com provides analysis of the global enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

About this Report

This report presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales forecasts by country and market segment, including:

- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for majo...

$6,500.00

2025 Global Respiratory Disease Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts--Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

Mon, 16 Mar 2020 13:31:40 +0000

This new 366-page report from LeadingMarketResearch.com contains 116 tables and provides analysis of the global respiratory disease testing market, including emerging tests, technologies, sales forecasts by country, market shares, and strategic profiles of leading suppliers....

$4,500.00

Microbiology/Infectious Diseases Database

Thu, 02 Nov 2023 15:47:24 +0000

Our unique Microbiology/Infectious Diseases Database contains granular information and analyses for over 100 countries, not available from any other source.

The database allows you to easily select only the specific information you need that precisely meets your objectives and budget.

...

$0.00

World Infectious Disease Testing Market for Over 100 Tests: A 92-Country Database and Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

Wed, 28 Oct 2020 12:26:38 +0000

This unique 92-country survey from LeadingMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The report provides granular market segmentation analysis and forecasts for over 100 microbiology tests; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and strategies for suppliers.

...

$18,500.00

POC Infectious Disease Testing Market for 100 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review--Physician Offices, Emergency Rooms, Ambulatory, Birth and Surgery Centers

Tue, 30 Jul 2019 12:07:23 +0000

This new 795-page report from LeadingMarketResearch.com contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market. ...

$2,500.00

Rapid Lateral Flow Diagnostics Market: Africa, Asia, Latin America, Middle East--Dengue Fever, H. Pylori, HBs Ag, Syphilis, Toxoplasmosis, Typhoid Fever (DataPack)

Wed, 18 Dec 2019 12:24:56 +0000

This unique 8-country report from LeadingMarketResearch.com provides granular data not available from any other source.

Lateral Flow Tests Analyzed in the Report

-Dengue Fever -Helicobacter Pylori -HBs Ag -Syphilis -Toxoplasmosis -Typhoid Fever

Country Analyses

Brazil India Indonesia Iraq Peru Saudi Arabia South Africa Vietnam

Sales and Market Share Analysis

For each test and country, the report provides sales and market shares for the following suppliers:

Abbott/Alere Abnova Arkray Beckman Coulter/Danaher bioMerieux Biopanda Bio-Rad EMDMIllipore IDL Biotech J Mitra LifeAssay Meridan Bioscience Quidel Trinity Biotech Wama

List of Tables

Table 1 Dengue Fever Rapid Lateral Flow Testing Market Volume And Sales Forecasts By Country

Table 2 Helicobacter Pylori Rapid Lateral Flow Testing Market Volume And Sales Forecasts By Country

Table 3 HBsAg Rapid Lateral Flow Testing Market Volume And Sales Forecasts By Country

Table 4 Syphilis Rapid Lateral Flow Testing Market Vol...

$4,500.00

Europe Infectious Disease Testing Market for Over 100 Tests: A 38-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

Tue, 06 Oct 2020 13:36:39 +0000

This new report from LeadingMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

$3,450.00

Latin America Infectious Disease Testing Market for Over 100 Tests: A 22-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

Tue, 06 Oct 2020 13:36:39 +0000

$2,450.00

POC Molecular Infectious Disease Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers--Supplier Shares and Competitive Strategies, Test Volume & Sales Segment Forecasts, Innovative Technologies, Instrumentation

Tue, 17 May 2022 11:45:55 +0000

This new report from LeadingMarketResearch.com contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market. $1,450.00

2023-2027 Rapid Lateral Flow Diagnostics Market: Africa, Asia, Latin America, Middle East--Dengue Fever, H. Pylori, HBs Ag, Syphilis, Toxoplasmosis, Typhoid Fever

Wed, 21 Jun 2023 16:19:49 +0000

This unique 8-country report from LeadingMarketResearch.com provides granular data not available from any other source.

Lateral Flow Tests Analyzed in the Report

-Dengue Fever -Helicobacter Pylori -HBs Ag -Syphilis -Toxoplasmosis -Typhoid Fever

Country Analyses

Brazil India Indonesia Iraq Peru Saudi Arabia South Africa Vietnam

Sales and Market Share Analysis

For each test and country, the report provides sales and market shares for the following suppliers:

Abbott/Alere Abnova Arkray Beckman Coulter/Danaher bioMerieux Biopanda Bio-Rad EMDMIllipore IDL Biotech J Mitra LifeAssay Meridan Bioscience Quidel Trinity Biotech Wama

List of Tables

Table 1 Dengue Fever Rapid Lateral Flow Testing Market Volume And Sales Forecasts By Country

Table 2 Helicobacter Pylori Rapid Lateral Flow Testing Market Volume And Sales Forecasts By Country

Table 3 HBsAg Rapid Lateral Flow Testing Market Volume And Sales Forecasts By Country

Table 4 Syphilis Rapid Lateral Flow Testing Market Vol...

$950.00

2023-2027 Vector-Borne Disease Diagnostics Market: Africa, Asia, Latin America, Middle East

Wed, 21 Jun 2023 16:19:49 +0000

This unique 8-country report from LeadingMarketResearch.com provides granular data not available from any other source.

Lateral Flow Tests Analyzed in the Report

-Dengue Fever -Helicobacter Pylori -HBs Ag -Syphilis -Toxoplasmosis -Typhoid Fever

Country Analyses

Brazil India Indonesia Iraq Peru Saudi Arabia South Africa Vietnam

Sales and Market Share Analysis

For each test and country, the report provides sales and market shares for the following suppliers:

Abbott/Alere Abnova Arkray Beckman Coulter/Danaher bioMerieux Biopanda Bio-Rad EMDMIllipore IDL Biotech J Mitra LifeAssay Meridan Bioscience Quidel Trinity Biotech Wama

List of Tables

Table 1 Dengue Fever Rapid Lateral Flow Testing Market Volume And Sales Forecasts By Country

Table 2 Helicobacter Pylori Rapid Lateral Flow Testing Market Volume And Sales Forecasts By Country

Table 3 HBsAg Rapid Lateral Flow Testing Market Volume And Sales Forecasts By Country

Table 4 Syphilis Rapid Lateral Flow Testing Market Vol...

$950.00

QuidelOrtho: Infectious Disease/Microbiology Market Shares and Competitive Position by Product and Country-- US, Europe, Japan--Performance, Capabilities, Goals and Strategies

Wed, 08 Jul 2020 13:25:34 +0000

This unique market intelligence report from LeadingMarketResearch provides information not available from any other published source. The report includes infectious disease/microbiology sales and market share estimates by product and country for QuidelOrtho and its main competitors, as well as a profile of the company's diagnostics business.

List of Tables

QuidelOrtho France AIDS Testing Market Supplier Sales and Market Shares QuidelOrtho France Chlamydia Testing Market Diagnostics Sales by Major Supplier QuidelOrtho France CMV Testing Market Diagnostics Sales by Major Supplier QuidelOrtho France Hepatitis Testing Market Diagnostics Sales by Major Supplier QuidelOrtho France Hepatitis C Testing Market Diagnostics Sales by Major Supplier QuidelOrtho France Influenza Testing Market Diagnostics Sales by Major Supplier QuidelOrtho France Meningitis Testing Market Diagnostics Sales by Major Supplier QuidelOrtho France RSV Testing Market Diagnostics Sales by Major Supplier QuidelOrtho France Rubella Testing Market Diagnostics Sales by Major Supplier QuidelOr...

$750.00

Latin America Infectious Disease Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Competitive Strategies, Instrumentation, Technologies, Opportunities

Mon, 30 Jan 2017 13:40:36 +0000

This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future market and technological trends; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

To fit your research budget and receive sections of this report or specific data on geographic regions, countries, markets, companies, technologies and products, select the exact information you need from our In...

$3,750.00

Escherichia Coli Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fri, 21 Oct 2022 16:02:05 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Escherichia coli Infections - Drugs In Development, 2022, provides an overview of the Escherichia coli Infections (Infectious Disease) pipeline landscape.

Escherichia coli (E. coli) bacteria normally live in the intestines of healthy people and animals. Escherichia coli infections are caused by coming into contact with the feces, or stool, of humans or animals or drink water or eat food that has been contaminated by feces. Symptoms include diarrhea, which may range from mild and watery to severe and bloody, abdominal cramping, pain or tenderness, nausea and vomiting. The predisposing factors include age, weakened immune systems and eating certain types of food like undercooked hamburger, unpasteurized milk, apple juice or cider and soft cheeses made from raw milk. Treatment includes antibiotics and healthy life style.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Escherichia coli Infections - Drugs...

$2,000.00

Vancomycin-Resistant Enterococcus Faecium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fri, 21 Oct 2022 16:02:05 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vancomycin-Resistant Enterococcus faecium Infections - Drugs In Development, 2022, provides an overview of the Vancomycin-Resistant Enterococcus faecium Infections (Infectious Disease) pipeline landscape.

Pathogenic strains of Enterococcus resistant to vancomycin are termed as Vancomycin-Resistant Enterococcus (VRE). Vancomycin-resistant enterococci have become a source of nosocomial infections. The symptoms of Vancomycin-resistant enterococci infection depend on where the infection lies. The bacteria usually infect the intestines, wounds and urinary tract. In case of wound infection, the area infected will be red and tender as well as swollen. In case of urinary tract infection, back pain and burning could occur when urination takes place. Other symptoms include nausea, fever, chills, severe headaches and diarrhea. Prevention requires effective hygienic practices.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pi...

$2,000.00

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fri, 21 Oct 2022 16:02:05 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Drugs In Development, 2022, provides an overview of the Methicillin-Resistant Staphylococcus aureus (MRSA) Infections (Infectious Disease) pipeline landscape.

MRSA infections that are acquired by persons who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as community-acquired MRSA (CA-MRSA) infections. Risk factors are hemodialysis, weakened immune system, admission to hospitals and wounds. Symptoms include skin rashes, fatigue, chest pain, fever and swelling. MRSA can be managed by the use of antibiotics and by maintaining hygienic conditions.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Drugs In Development, 2022, provides comprehensive information on the therapeutics under developme...

$2,500.00

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fri, 21 Oct 2022 16:02:05 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Drugs In Development, 2022, provides an overview of the Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections (Infectious Disease) pipeline landscape.

Methicillin-Susceptible Staphylococcus aureus (MSSA) is a bacterium that is resistant to many antibiotics. MSSA usually cause skin infections, but can also cause pneumonia, and other serious types of infections. Symptoms include cellulitis, painful rashes, nausea and vomiting, fever, muscle aches, diarrhea and abdominal pain. Predisposing factors include weakened immune systems, burns and surgical wounds.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Methicillin-Susceptible Staphylococcus aureus (MSSA) Infec...

$2,000.00

Cytomegalovirus (HHV-5) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fri, 21 Oct 2022 16:02:05 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus (HHV-5) Infections - Drugs In Development, 2022, provides an overview of the Cytomegalovirus (HHV-5) Infections (Infectious Disease) pipeline landscape.

Cytomegalovirus (CMV) is a contagious infection of the caused by the member of the herpes virus family. CMV is spread through saliva or urine. Symptoms include fever, pneumonia, weight loss, hearing, neurological and developmental problems. The predisposing factors are exposure direct contact with infected surface or organism, weakened immune system and congenital factors. It may be diagnosed by blood or urine tests. The condition may be controlled by the use of medication such as anti-viral and may be prevented by lifestyle modification.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Cytomegalovirus (HHV-5) Infections - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Cytomegal...

$2,000.00

Vector-Borne Disease Diagnostics Market: Africa, Asia, Latin America, Middle East

Wed, 24 Mar 2021 10:30:17 +0000

This unique 8-country report from LeadingMarketResearch.com provides granular data not available from any other source.

Lateral Flow Tests Analyzed in the Report

-Dengue Fever -Helicobacter Pylori -HBs Ag -Syphilis -Toxoplasmosis -Typhoid Fever

Country Analyses

Brazil India Indonesia Iraq Peru Saudi Arabia South Africa Vietnam

Sales and Market Share Analysis

For each test and country, the report provides sales and market shares for the following suppliers:

Abbott/Alere Abnova Arkray Beckman Coulter/Danaher bioMerieux Biopanda Bio-Rad EMD MIllipore IDL Biotech J Mitra LifeAssay Meridan Bioscience Quidel Trinity Biotech Wama

List of Tables

Table 1 Dengue Fever Rapid Lateral Flow Testing Market Volume And Sales Forecasts By Country

Table 2 Helicobacter Pylori Rapid Lateral Flow Testing Market Volume And Sales Forecasts By Country

Table 3 HBsAg Rapid Lateral Flow Testing Market Volume And Sales Forecasts By Country

Table 4 Syphilis Rapid Lateral Flow Testing Market Vo...

$4,500.00

USA Respiratory Disease Market: Shares and Segment Forecasts-- Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis

Tue, 15 Feb 2022 11:06:17 +0000

This new report from LeadingMarketResearch.com provides analysis of the US respiratory disease testing market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors.

About this Report

This report presents detailed analysis of the Respiratory Disease market in France.

Current scientific views on epidemiology and etiology are presented for:

Adenovirus Coronavirus Enterovirus Influenza Legionella Mononucleosis Mycoplasma Pneumonia RSV Rhinovirus Tuberculosis

The report provides test volume and sales forecasts by country and market segment.

The report is available by section, and can be customized to specific information needs and budget.

In addition to market share and sales forecasts, the report:

- Examines market applications of molecular diagnostics, monoclonal antibodies, immunoassays, IT and other technologies.

- Reviews features and operating characteristics of major analyzers used for respiratory dis...

$1,500.00

UK Respiratory Disease Market: Shares and Segment Forecasts-- Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis

Tue, 15 Feb 2022 11:06:17 +0000

This new report from LeadingMarketResearch.com provides analysis of the UK respiratory disease testing market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors.